iohexol has been researched along with Minimal Disease, Residual in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belsack, D; Buls, N; de Mey, J; Everaert, H; Ilsen, B; Ros, PR; Vandemeulebroucke, J; Vandenbroucke, F; Verdries, D | 1 |
| Horger, M; Löffler, S; Sauter, A; Schulze, M; Sökler, M; Spira, D; Vogel, W | 1 |
| Akin, O; Barakat, RR; Chi, DS; Hricak, H; Iyer, RB; Lakhman, Y; Moskowitz, CS; Sabbatini, PJ; Sohn, MJ; Zheng, J | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Kuehl, H; Stergar, H; Veit, P | 1 |
| Albanese, V; Barone, F; Mancuso, P; Nicoletti, GF; Passanisi, M | 1 |
1 trial(s) available for iohexol and Minimal Disease, Residual
| Article | Year |
|---|---|
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.
Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iohexol; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
4 other study(ies) available for iohexol and Minimal Disease, Residual
| Article | Year |
|---|---|
Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
Topics: Catheter Ablation; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Iohexol; Liver Neoplasms; Metastasectomy; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Size and attenuation CT (SACT) of residual masses in patients with follicular non-Hodgkin lymphoma: more than a status quo?
Topics: Adult; Aged; Contrast Media; Female; Humans; Iohexol; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Neoplasm, Residual; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.
Topics: Contrast Media; Diatrizoate; Disease Progression; Fallopian Tube Diseases; Female; Humans; Iohexol; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Postoperative Period; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Linear contrast enhancement at the operative site on early post-operative CT after removal of brain tumors.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Contrast Media; Female; Glioblastoma; Gliosarcoma; Humans; Iohexol; Male; Medulloblastoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Postoperative Period; Predictive Value of Tests; Supratentorial Neoplasms; Tomography, X-Ray Computed | 1994 |